Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. - Wikidata - awgldk - TriplyDB

Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease.

Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease.

http://www.wikidata.org/entity/Q40422877

about

Circulating Endothelial Microparticles: A Key Hallmark of Atherosclerosis Progression Clinical significance of procoagulant microparticles Endothelial Microparticles Act as Novel Diagnostic and Therapeutic Biomarkers of Diabetes and Its Complications: A Literature Review Novel methodologies for biomarker discovery in atherosclerosis p75(NTR)-dependent activation of NF-κB regulates microRNA-503 transcription and pericyte-endothelial crosstalk in diabetes after limb ischaemia Prothrombotic markers and early spontaneous recanalization in ST-segment elevation myocardial infarction Expression-based network biology identifies alteration in key regulatory pathways of type 2 diabetes and associated risk/complications Aorta fluorescence imaging by using confocal microscopy.Endothelial Extracellular Vesicles-Promises and Challenges Type 2 scavenger receptor CD36 in platelet activation: the role of hyperlipemia and oxidative stress.CD144+ endothelial microparticles as a marker of endothelial injury in neonatal ABO blood group incompatibility.Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation.The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases.Circulating endothelial microparticles in diabetes mellitus Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study.Relationship of microparticles to progenitor cells as a measure of vascular health in a diabetic population Inflammation-induced endothelial cell-derived extracellular vesicles modulate the cellular status of pericytes.Vascular inflammation and endothelial dysfunction in experimental hypertension.Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers.Racial differences in tumor necrosis factor-α-induced endothelial microparticles and interleukin-6 production.Restoration of glycemic control in patients with type 2 diabetes mellitus after bariatric surgery is associated with reduction in microparticles.Microparticle Shedding from Neural Progenitor Cells and Vascular Compartment Cells Is Increased in Ischemic Stroke.Role of eNOS- and NOX-containing microparticles in endothelial dysfunction in patients with obesity.Identification of plasma vascular endothelia-cadherin as a biomarker for coronary artery disease in Type 2 diabetes mellitus patients.Cellular imaging in drug discovery.Platelet CD36 mediates interactions with endothelial cell-derived microparticles and contributes to thrombosis in mice.Disturbed blood flow acutely induces activation and apoptosis of the human vascular endothelium.Microvesicles and diabetic complications--novel mediators, potential biomarkers and therapeutic targets.Plasma microparticles and vascular disorders.Obesity and sexual dysfunction, male and female.Personalized cytomic assessment of vascular health: Evaluation of the vascular health profile in diabetes mellitus.Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence The relationship of systemic markers of renal function and vascular function with retinal blood vessel responses.Are endothelial microparticles potential markers of vascular dysfunction in the antiphospholipid syndrome?Annual FEV1 changes and numbers of circulating endothelial microparticles in patients with COPD: a prospective study Endothelial cells microparticle-associated protein disulfide isomerase promotes platelet activation in metabolic syndrome.Microparticles--messengers of biological information.Extracellular heat shock proteins, cellular export vesicles, and the Stress Observation System: a form of communication during injury, infection, and cell damage. It is never known how far a controversial finding will go! Dedicated to Ferruccio Rito Endothelial mechanisms of endothelial dysfunction in patients with obstructive sleep apnea.The assessment of vascular function during dietary intervention trials in human subjects.

P2860

Q26749422-2355A78E-80B4-4859-B24E-80FE02751150 Q26830846-7602F5F5-9B1D-4062-8BC4-E83A249DCB16 Q28071774-A8479867-0F10-4AA0-B631-DC4DB1783268 Q28088373-ED093662-DB50-40B7-BBD1-59C6F7BAC73F Q28117855-270F350A-FC7B-4D34-A09C-E004E8254BDA Q28220222-E68F1763-6EE8-4A9C-8BD4-DE786445D323 Q28472170-D16176FA-9435-4B8C-B5C8-9DCEB7AEB48B Q30470431-DF2B1559-E575-4C74-90D6-47B1410C55B0 Q33639065-C4424F60-952B-4A57-807B-E7C5D07E72E4 Q33641499-C9AA43DD-34C2-4540-B5A7-82A25A8A4568 Q33690900-96015954-83D2-4627-B36C-28CC7A69022E Q33857901-1B7FC405-24DD-4AA7-B3F3-07912E04E335 Q33916623-274BCD0E-D883-4161-841C-F33B98E84403 Q33996570-AA0F002F-A2AC-4AAE-8C52-53A7A7DE6990 Q34469009-8FC99C55-1B9F-4479-8A83-E32E4FB6A744 Q34488533-99757CED-F03E-4429-A410-1E9EF1110B08 Q35089453-D498D7EC-92D7-438E-ACD5-2DA00E578BAF Q35207893-C18BE34A-9F98-443F-8B75-C9B7D974763C Q35212590-6723B070-F63A-4D5E-9541-1E68E01691EB Q35233331-E8CE3046-30C0-4893-A7E2-289096EE21D0 Q35850777-66FDA108-D347-401C-AA7C-DA4217DCCD3C Q35905659-FD0942E8-6858-49FE-AF9E-A65B950B46E3 Q36003956-94995A57-0584-40FE-9A06-411B8B664F34 Q36412326-48C23332-3B7D-4B38-BD0B-A07D7F44F462 Q36438745-A1F62C80-AF57-4CBF-B511-6CE8B1DFD961 Q36570485-EC7EDE74-1EA8-4CE7-851C-40954D5FBDF7 Q36630135-329DF908-2DCD-4B8C-B51D-43D5A06D6863 Q36745194-BB1F6D1F-E8AC-41FA-8474-ACE95AD3871C Q36759589-592C5E3F-10D4-43D8-9CAB-BD5CBC094802 Q37133986-1496031C-98F7-40D4-9DB0-241A19ACB4AC Q37267758-E1D9BD86-7DF1-48B9-B802-14F9DC4A6FAD Q37293820-F0793E07-88D8-4E7D-9AF7-E676F887DF23 Q37366171-E43D208A-FE70-4918-86CA-8C1096BED331 Q37510353-A29F729A-DC9E-4031-B5D7-668D18135519 Q37628496-C76084B8-E767-41EF-A8F0-A40495DA0707 Q37696296-A2358D87-EFB8-40A6-B22B-398497319275 Q37769584-BE588389-2CE6-4D0B-99C2-ECC9F2150076 Q37801877-B66BE623-28BD-49C6-B430-9CA95A326A47 Q37863567-B09E20A7-CC48-4DB4-9F98-C8A4CFEACEE4 Q37898220-2D9C1A2B-B559-4576-AF3A-DE10ACF48C56

P2860

Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease.

http://www.wikidata.org/entity/Q40422877

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Elevated levels of VE-cadherin ...... s and coronary artery disease.

@en

type

label

Elevated levels of VE-cadherin ...... s and coronary artery disease.

@en

prefLabel

Elevated levels of VE-cadherin ...... s and coronary artery disease.

@en

P1433

Q40422877-5F098C67-9DF8-492B-BBE5-84954F8D27F6

P1476

Q40422877-A1AA9B94-A3C7-4EF0-BA96-3D30EDADF2EF

P2093

Q40422877-377B8712-9531-4808-8492-E88BC5A69E84

Q40422877-3E905EAC-455F-4748-8F7C-92309DD5961D

Q40422877-462E6424-BD7D-4F32-8C43-B8F9FC0F685F

Q40422877-6F43A254-CCA5-485C-A7FB-A7CDCFFA096A

Q40422877-73E21EB3-3494-4C79-8FFA-1E3DC8846C52

Q40422877-7617265B-F1D6-4FAC-B457-C623926552C3

Q40422877-927C2FB9-8F66-4AF3-8C6E-C27424E7E993

Q40422877-B6BC6154-3DA1-44EC-AEE0-6A0CB6AB752A

Q40422877-CCB23FF2-79F9-4FA7-AE09-722A87477213

Q40422877-E3B41578-AFFE-498B-8468-60730CDA03D5

P304

Q40422877-2DB2E4B9-740C-49A8-AEB8-11D6CC9F171C

P31

Q40422877-793892DE-ACD1-4B54-8590-CE273E93EEFB

P356

Q40422877-E54CE298-50EC-4E70-A5AC-45C77E65B051

P407

Q40422877-54FC63B4-08D1-423B-BFEF-F81E657134CC

P433

Q40422877-2D266029-466E-4949-B088-072918846CC4

P478

Q40422877-DF74B329-CD28-4525-A681-337D67B80C86

P577

Q40422877-D70B91BA-77FC-48DE-8BD9-554F10E55CF3

P5875

Q40422877-AF69A992-FED5-4154-89CD-532C09683376

P698

Q40422877-A9E77579-C47F-4B2B-843D-94A6E52CE9F3

P921

Q40422877-442ABE95-E90B-460D-9C0F-CD5FA628AB01

Q40422877-7E48E01A-9C41-4570-B72B-2DBE2BF813CA

P356

J.JACC.2005.02.047

P1433

Journal of the American College of Cardiology

P1476

Elevated levels of VE-cadherin ...... s and coronary artery disease.

@en

P2093

Hideaki Jinnouchi

http://www.w3.org/2001/XMLSchema#string

Hidenobu Koga

http://www.w3.org/2001/XMLSchema#string

Hironobu Fukushima

http://www.w3.org/2001/XMLSchema#string

Hisao Ogawa

http://www.w3.org/2001/XMLSchema#string

Keisuke Watanabe

http://www.w3.org/2001/XMLSchema#string

Kiyotaka Kugiyama

http://www.w3.org/2001/XMLSchema#string

Michihiro Yoshimura

http://www.w3.org/2001/XMLSchema#string

Seigo Sugiyama

http://www.w3.org/2001/XMLSchema#string

Tomohiro Sakamoto

http://www.w3.org/2001/XMLSchema#string

Tomoko Tanaka

http://www.w3.org/2001/XMLSchema#string

P304

1622-1630

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACC.2005.02.047

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7848555

http://www.w3.org/2001/XMLSchema#string

P698

15893178

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes